Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
Top Cited Papers
- 26 July 2012
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 367 (4) , 319-328
- https://doi.org/10.1056/nejmoa1203858
Abstract
The provision of sufficient basal insulin to normalize fasting plasma glucose levels may reduce cardiovascular events, but such a possibility has not been formally tested.Keywords
This publication has 28 references indexed in Scilit:
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific DeathNew England Journal of Medicine, 2011
- Serious Cardiovascular Outcomes in DiabetesCirculation, 2011
- Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART studyDiabetologia, 2010
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studiesThe Lancet, 2010
- Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic AdultsNew England Journal of Medicine, 2010
- Intensive glucose control and macrovascular outcomes in type 2 diabetesDiabetologia, 2009
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studiesDiabetes Research and Clinical Practice, 2007
- Pathogenesis of Type 2 DiabetesEndocrine Research, 2007
- INSULIN RATHER THAN GLUCOSE HOM$OElig;OSTASIS IN THE PATHOPHYSIOLOGY OF DIABETESThe Lancet, 1976